Salamanca Press

Marks the First-Ever Global Pediatric Trial for Menin Inhibitors The PedAL (Pediatric Acute Leukemia) Master Trial is at the heart of LLS's Dare to Dr...

Business & Community Leaders Join The Leukemia & Lymphoma Society's 2025 Visionaries of the Year 36 th Annual Philanthropic Competition WASHINGTON , A...

First-hand Patient Accounts Provide Unique Insight WASHINGTON , March 4, 2025 /PRNewswire/ --The Leukemia & Lymphoma Society (LLS) has launched a new ...

WASHINGTON , Feb. 11, 2025 /PRNewswire/ -- As the nation's largest organization serving the critical needs of blood cancer patients, we are alarmed by...

The organization will enable blood cancer patients to gain one million years of life by 2040 RYE BROOK, N.Y. , Jan. 31, 2025 /PRNewswire/ -- Celebrati...

Lore Gruenbaum , Ph.D., will oversee the planning and execution of the strategy for all LLS's research programs Dr. Gruenbaum succeeds Lee Greenberger...

SAN DIEGO , Dec. 9, 2024 /PRNewswire/ -- Using the latest cutting-edge genetic tools, Elvin Wagenblast , Ph.D., is dissecting blood cells to explain e...

New data from LLS first-of-its-kind master clinical trials — Beat AML® and Pediatric Acute Leukemia (PedAL) — show promise for hard-to-treat leukemias...

RYE BROOK,N.Y. , Nov. 12, 2024 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is kicking off the ski season by gathering communities nationwide...